In postmenopausal women with early breast cancer, longitudinal studies reported short-term increases of 15–48% in IL-6, IL-8, IFN-γ, TNF-α, and IL-10 after adjuvant chemotherapy, returning toward baseline within 6–12 months [22]. This evidence concerns the gene IL10 and breast cancer.